4//SEC Filing
Imprimis Pharmaceuticals, Inc. 4
Accession 0001493152-17-006713
$HROWCIK 0001360214operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:00 PM ET
Size
5.8 KB
Accession
0001493152-17-006713
Insider Transaction Report
Form 4
AUSTIN STEPHEN G
Director
Transactions
- Award
RSU
2017-06-13+15,723→ 15,723 totalExercise: $0.00From: 2017-06-13Exp: 2018-06-13→ Common Stock (15,723 underlying)
Footnotes (2)
- [F1]Award of Restricted Stock Units vests quarterly in equal installments over a one year period following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.
- [F2]The Restricted Stock Units were received as a compensatory award for no consideration.
Documents
Issuer
Imprimis Pharmaceuticals, Inc.
CIK 0001360214
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001360214
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 6:00 PM ET
- Size
- 5.8 KB